Imbalance of growth factor signalling in diabetic kidney disease: Is connective tissue growth factor (CTGF, CCN2) the perfect intervention point?

Nephrology Dialysis Transplantation

Volumn 20, Issue 1, 2005, Pages 6-10

  van Nieuwenhoven, Frans A ^a   Jensen, Louise J N ^b   Flyvbjerg, Allan ^b   Goldschmeding, Roel ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Clinical marker; CTGF; Diabetes, nephropathy; Therapy

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CONNECTIVE TISSUE GROWTH FACTOR; MATRIX METALLOPROTEINASE; SOMATOMEDIN BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VON WILLEBRAND FACTOR;

CARBOXY TERMINAL SEQUENCE; DIABETIC NEPHROPATHY; EDITORIAL; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GLOMERULUS FILTRATION; HUMAN; IN SITU HYBRIDIZATION; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA; URINARY EXCRETION;

BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA;

EID: 13444250205     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh570     Document Type: Editorial

References (31)

1. Ziyadeh FN, Sharma K. Overview: combating diabetic nephropathy. J Am Soc Nephrol 2003; 14: 1355-1357
2. Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003; 14: 1358-1373
3. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000; 43: 1205-1223
4. Wang S, Chen Q, Simon TC et al. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 2003; 63: 2037-2049
5. Goldschmeding R, Aten J, Ito Y et al. Connective tissue growth factor: just another factor in renal fibrosis? Nephrol Dial Transplant 2000; 15: 296-299
6. Brigstock DR. The CCN family: a new stimulus package. J Endocrinol 2003; 178: 169-175
7. Gao R, Brigstock DR. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 2004; 279: 8848-8855
8. Gao R, Brigstock DR. Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 2003; 27: 214-220
9. Lam S, van der Geest RN, Verhagen NA et al. Connective tissue growth factor and IGF-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes 2003; 52: 2975-2983
10. Hashimoto G, Inoki I, Fujii Y et al. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 2002; 11: 11
11. Abreu JG, Ketpura NI, Reversade B et al. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nature Cell Biol 2002; 4: 599-604
12. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000; 49: 1399-1408
13. Ito Y, Aten J, Bende RJ et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998; 53: 853-861
14. Twigg SM, Cooper ME. The time has come to target connective tissue growth factor in diabetic complications. Diabetologia 2004; 47: 965-968
15. Roestenberg P, Martens P, Joles J et al. Upregulation of connective tissue growth factor (CTGF) in glomerular epithelial cells of mice with STZ-induced diabetes mellitus. J Am Soc Nephrol 2004; 15 [abstract]: in press
16. Adler SG, Kang SW, Feld S et al. Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy. Kidney Int 2001; 60: 2330-2336
17. Riser BL, Cortes P, DeNichilo M et al. Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int 2003; 64: 451-458
18. Gilbert RE, Akdeniz A, Weitz S et al. Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Diabetes Care 2003; 26: 2632-2636
19. Roestenberg P, van Nieuwenhoven FA, Wieten L et al. Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care 2004; 27: 1164-1170
20. van Nieuwenhoven FA, Rossing K, Andersen S et al. Beneficial effect of dual blockade of the renin-angiotensin system (RAS) on urinary connective tissue growth factor (CTGF) in type 2 diabetic patients with nephropathy. Diabetologia 2004; 47: A386 [abstract]
21. Andersen S, van Nieuwenhoven FA, Rossing P et al. Reduction of urinary connective tissue growth factor by losartan in hypertensive type 1 diabetic patients with diabetic nephropathy. Diabetologia 2004; 47: A387 [abstract]
22. Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 2002; 21: 473
23. Twigg SM, Cao Z, SV MC et al. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 2002; 143: 4907-4915
24. Mori T, Kawara S, Shinozaki M et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 1999; 181: 153-159
25. Ivkovic S, Yoon BS, Popoff SN et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003; 130: 2779-2791
26. Roestenberg P, Verheul R, Lyons K et al. Connective tissue growth factor (CTGF) expression level in podocytes relates to glomerular basement membrane (GBM) thickening in STZ-induced diabetes mellitus. J Am Soc Nephrol 2004; 15 [abstract]: in press
27. Franklin TJ. Therapeutic approaches to organ fibrosis. Int J Biochem Cell Biol 1997; 29: 79-89
28. Wahab NA, Yevdokimova N, Weston BS et al. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 2001; 359: 77-87
29. Yokoi H, Mukoyama M, Sugawara A et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol 2002; 282: F933-F942
30. Yokoi H, Mukoyama M, Nagae T et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 2004; 15: 1430-1440
31. Flyvbjerg A, Khatir D, Jensen LJN et al. Long-term renal effects of a neutralizing connective tissue growth factor (CTGF)-antibody in obese type 2 diabetic mice. J Am Soc Nephrol 2004; 15 [abstract]: in press